Get Ready to LOL: Processa Pharmaceuticals Drops the Deets on Q2 2022 Finances and Company Happenings!
Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update PCS12852 on target to complete enrollment by September Expanded efforts to increase enrollment in PCS499 and PCS6422 showing results Exciting news for Processa Pharmaceuticals, Inc. as they announce their second quarter 2022 financial results and provide a corporate update. With PCS12852 on track…